Published in Value Health on November 12, 2007
Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol (2008) 1.77
Patient involvement in the development of patient-reported outcome measures: a scoping review. Health Expect (2016) 1.67
Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas (2012) 1.26
Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology (2012) 1.10
Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes (2012) 0.98
Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes (2011) 0.97
The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development. Psychooncology (2013) 0.92
Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes (2009) 0.92
The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J (2015) 0.88
[Patient reported outcomes. Relevance and application in ophthalmology]. Ophthalmologe (2008) 0.84
Impact of blood pressure dysregulation on health-related quality of life in persons with spinal cord injury: development of a conceptual model. Arch Phys Med Rehabil (2013) 0.84
A quality-of-life measure for adults with primary ciliary dyskinesia: QOL-PCD. Eur Respir J (2015) 0.83
Lung transplantation for cystic fibrosis. Proc Am Thorac Soc (2009) 0.83
Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties. Health Qual Life Outcomes (2016) 0.82
Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis (2011) 0.81
Validation of Self-Management Screening (SeMaS), a tool to facilitate personalised counselling and support of patients with chronic diseases. BMC Fam Pract (2015) 0.80
Health-related quality of life in caregivers of individuals with traumatic brain injury: development of a conceptual model. Arch Phys Med Rehabil (2014) 0.79
Development of a measure of self-efficacy for acute headache medication adherence. J Behav Med (2015) 0.78
Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire. Melanoma Res (2012) 0.78
The Long-Term Conditions Questionnaire: conceptual framework and item development. Patient Relat Outcome Meas (2016) 0.78
Confirmatory Factor Analysis of the Patient Reported Outcomes Measurement Information System (PROMIS) Adult Domain Framework Using Item Response Theory Scores. Med Care (2015) 0.77
Advances in pediatrics in 2014: current practices and challenges in allergy, gastroenterology, infectious diseases, neonatology, nutrition, oncology and respiratory tract illnesses. Ital J Pediatr (2015) 0.77
The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence. J Cancer Surviv (2017) 0.76
The Cystic Fibrosis Symptom Progression Survey (CF-SPS) in Arabic: A Tool for Monitoring Patient's Symptoms. Oman Med J (2015) 0.75
Evaluation of measurement properties of self-administered PROMs aimed at patients with non-specific shoulder pain and "activity limitations": a systematic review. Qual Life Res (2016) 0.75
Development of a questionnaire to assess the impact on parents of their infant's bronchiolitis hospitalization. BMC Health Serv Res (2013) 0.75
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst (2005) 4.51
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA (2003) 4.31
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Spoken language development in children following cochlear implantation. JAMA (2010) 3.35
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol (2006) 2.22
Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer (2011) 2.18
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol (2003) 2.14
A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros (2006) 2.11
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain (2007) 2.07
Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med (2008) 2.05
Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage (2012) 1.97
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol (2012) 1.90
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol (2008) 1.77
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest (2009) 1.73
Patient-reported outcomes: conceptual issues. Value Health (2007) 1.72
Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. J Pediatr Psychol (2004) 1.72
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69
Authors' reply to Tendas et al. J Pain Symptom Manage (2013) 1.66
A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64
Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc (2007) 1.63
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck (2007) 1.63
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun (2010) 1.58
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage (2002) 1.58
Controlled evaluation of the STARBRIGHT CD-ROM program for children and adolescents with Cystic Fibrosis. J Pediatr Psychol (2004) 1.57
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52
Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain (2006) 1.48
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage (2003) 1.47
Predicting behavior problems in deaf and hearing children: the influences of language, attention, and parent-child communication. Dev Psychopathol (2009) 1.46
The role of statins in cancer therapy. Oncologist (2006) 1.46
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43
Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage (2003) 1.42
Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol (2010) 1.41
Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol (2012) 1.38
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatr Pulmonol (2010) 1.37
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros (2009) 1.35
Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain (2006) 1.33
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32
Speech recognition at 1-year follow-up in the childhood development after cochlear implantation study: Methods and preliminary findings. Audiol Neurootol (2006) 1.31
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30
[Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc) (2003) 1.26
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25
Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis. Arch Pediatr Adolesc Med (2009) 1.25
Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain (2004) 1.24
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol (2010) 1.23
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23
Tracking development of speech recognition: longitudinal data from hierarchical assessments in the Childhood Development after Cochlear Implantation Study. Otol Neurotol (2008) 1.20
Symptom burden in cancer survivorship. J Cancer Surviv (2007) 1.18
Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage (2005) 1.18
Identification of metastatic cancer in claims data. Pharmacoepidemiol Drug Saf (2012) 1.18
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17
Influence of implantation age on school-age language performance in pediatric cochlear implant users. Int J Audiol (2013) 1.17
Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol (2004) 1.15
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood (2013) 1.14
Language development after cochlear implantation: an epigenetic model. J Neurodev Disord (2011) 1.12
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
Interpreting and reporting results based on patient-reported outcomes. Value Health (2007) 1.12
Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2006) 1.12
Adherence with tobramycin inhaled solution and health care utilization. BMC Pulm Med (2011) 1.11
Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer (2010) 1.11
Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol (2002) 1.11
Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol (2010) 1.10
Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol (2010) 1.10
Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2005) 1.07
Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer (2006) 1.07
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys (2008) 1.05
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res (2013) 1.04
Analysis and interpretation of results based on patient-reported outcomes. Value Health (2007) 1.04
Identification of effective strategies to promote language in deaf children with cochlear implants. Child Dev (2012) 1.04
Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm (2006) 1.04
Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol (2004) 1.03
Parenting Stress among Parents of Deaf and Hearing Children: Associations with Language Delays and Behavior Problems. Parent Sci Pract (2010) 1.03
Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med (2009) 1.03
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst (2010) 1.03
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer (2010) 1.03
Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis. Chest (2010) 1.02
Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone (2012) 1.01
Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis. BMC Pulm Med (2010) 1.00
Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. J Cyst Fibros (2013) 1.00
The economic burden of anemia in cancer patients receiving chemotherapy. Value Health (2005) 1.00
Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res (2012) 1.00
Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatr Pulmonol (2010) 0.99
Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology (2008) 0.99
Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage (2007) 0.99
Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage (2008) 0.99
Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage (2006) 0.98
Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail (2008) 0.98